Anebulo Pharmaceuticals, Inc. (ANEB) は上場企業です ヘルスケア セクターの バイオテクノロジー 業界で事業展開. 本社所在地は Lakeway, TX, アメリカ. 現CEOは Richard Anthony Cunningham.
ANEB を有する IPO日 2021-05-07, 2 名の正社員, に上場 Other OTC, 時価総額 $20.39M.
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The company was incorporated in 2020 and is based in Lakeway, Texas.
